Dianthus Therapeutics Inc (DNTH)
R&D Expense Growth
41.00%
Quarterly · Period ending:
DNTH R&D Expense Growth
Latest reported41.00%period ending
Latest reported41.00%period ending
DNTH Quarterly R&D Growth (QoQ) (0.00% → 41.00%)
Latest values, visible window
High-resolution chart · PNG
DNTH r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 41.0044% | |
| -42.3525% | |
| 84.3547% | |
| 23.7629% | |
| -2.7849% | |
| 2.2337% | |
| 3.402% | |
| 41.3614% | |
| 38.171% | |
| 48.9352% | |
| 10.3141% | |
| -22.3642% | |
| 75.3549% | |
| -40.5249% | |
| 36.2012% | |
| -30.6428% | |
| -32.1445% | |
| 21.9254% | |
| 22.5665% | |
| -3.6338% | |
| -9.1917% | |
| -4.3081% | |
| 3.9878% | |
| -6.5345% | |
| -9.6899% | |
| -25.3874% | |
| 13.2534% | |
| 23.0105% | |
| 27.4841% | |
| -14.9556% | |
| 8.5129% | |
| 17.918% | |
| 23.366% | |
| 41.3979% | |
| 6.5451% | |
| -62.2901% | |
| 315.894% | |
| 0% |